Trofinetide for the Treatment of Rett Syndrome
Ponni Subbiah, MD, MPH, Senior Vice President Global Head of Medical Affairs and Chief Medical Officer, Acadia Pharmaceuticals, discusses trofinetide for the treatment of Rett syndrome.
Ponni Subbiah, MD, MPH, Senior Vice President Global Head of Medical Affairs and Chief Medical Officer, Acadia Pharmaceuticals, discusses trofinetide for the treatment of Rett syndrome.
Brahm Goldstein, MD, Vice President, R&D, Hematology at CSL Behring, discusses HEMGENIX, a pivotal gene therapy for hemophilia B.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Researchers are using computer and AI technologies to create a Caregiving Robot Assistant (CART) for ALS patients and their caregivers.
An estimated 5.4 million children help care for relatives, as families can’t afford or find other in-home care.
Doris Hansen, MD, discusses the treatment of multiple myeloma using D-Rd and V-Rd in transplant-ineligible patients.
Hesham Abdullah, MD, MSc, of GSK, discusses myelofibrosis and the uses of momelotinib, also known as Ojjaara, to treat it.
The agency seeks feedback at a 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special…
The Isabel Zendal Nursing Hospital in the Community of Madrid is now home to a specialized Day…
A big boost is coming to local ALS research in the form of $13.5 million gift to the University of Cincinnati’s Gardner Neuroscience Institute.